Proteomecentric

Proteomecentric describes an approach or perspective in molecular biology and biomedical research that prioritizes the proteome—the complete set of proteins expressed in a cell, tissue, or organism—over or alongside genomic and transcriptomic information. The term is used to emphasize direct measurement and analysis of proteins, their abundances, interactions, modifications, and functional states as primary sources of biological insight.

Proteomecentric strategies commonly employ mass spectrometry-based proteomics, including discovery and targeted workflows, as well as affinity-based assays and imaging methods. These techniques enable identification and quantification of thousands of proteins, characterization of post-translational modifications, and mapping of protein-protein interaction networks. Bioinformatic tools and databases support data processing, normalization, and functional annotation.

Applications of a proteomecentric focus include biomarker discovery, drug target identification, systems biology modeling, and clinical proteomics for disease stratification and therapeutic monitoring. Because proteins are the primary effectors of cellular function and often undergo regulation not directly predicted by gene expression, proteomecentric analyses can reveal functional changes missed by genomic or transcriptomic studies.

Limitations and challenges associated with proteomecentric approaches include the dynamic range of protein expression, sample complexity, variability in sample preparation, and the computational demands of large datasets. Integration with genomics and transcriptomics—proteogenomics—can mitigate some limitations by combining complementary data types, enabling more comprehensive biological interpretation.